Understanding the Behavior of Amorphous Pharmaceutical Systems during Dissolution

Overview of attention for article published in Pharmaceutical Research, February 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

patent: 12 patents

Citations

dimensions_citation: 392 Dimensions

Readers on

mendeley: 318 Mendeley
citeulike: 1 CiteULike

Summary Patents Dimensions citations

So far, Altmetric has seen 12 patents that reference this research output.

PHARMACEUTICAL COMPOSITION CONTAINING REGORAFENIB AND A STABILIZING AGENT

Application WO-2021156172-A1

World Intellectual Property Organisation (WIPO)

12 Aug 2021

PHARMACEUTICAL COMPOSITION CONTAINING REGORAFENIB AND A STABILIZING AGENT

Application EP-3861989-A1

European Patent Office

11 Aug 2021

Formulations of pyrimidinedione derivative compounds

Application US-10201542-B2

United States of America

12 Feb 2019

Compositions and methods for treating HCV

Grant US-10201584-B1

United States of America

12 Feb 2019

Compositions and methods for treating HCV

Grant US-10201541-B1

United States of America

12 Feb 2019

Solid antiviral dosage forms

Grant US-10105365-B2

United States of America

23 Oct 2018

Surfactant-free HIV protease inhibitor composition and method of manufacturing thereof

Grant US-10034865-B2

United States of America

31 Jul 2018

Solid antiviral dosage forms

Grant US-9744170-B2

United States of America

29 Aug 2017

Formulations of pyrimidinedione derivative compounds

Grant US-9629841-B2

United States of America

25 Apr 2017

FILM DOSAGE FORMS CONTAINING AMORPHOUS ACTIVE AGENTS

Application US-20160324773-A1

United States of America

10 Nov 2016

Solid antiviral dosage forms

Grant US-9333204-B2

United States of America

10 May 2016

FORMULATIONS OF PYRIMIDINEDIONE DERIVATIVE COMPOUNDS

Application WO-2014063101-A1

World Intellectual Property Organisation (WIPO)

24 Apr 2014